New Israeli Cancer Vaccine Triggers Response In 90% Of Cancer Types

Posted on January 19, 2015 by akiramorikawa

An Israeli biotechnology company is developing immunotherapy that’s designed to prevent cancer from returning.

Source: nocamels.com

See on Scoop.it – iLife

About akiramorikawa

superconnection . pattern-recognition . iDesign
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s